Raymond James Financial Inc Charles River Laboratories International, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 231,720 shares of CRL stock, worth $38.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
231,720Holding current value
$38.5 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
51.7MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.01 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$846 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$622 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$354 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$323 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.46B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...